No side effects and pain relief – might be better than a biscuit!
“Clinical significance: This pharmacokinetic and clinical study suggests that 2 mg/kg [body weight every 12 hours] of CBD twice daily can help increase comfort and activity in dogs with OA.” Larger doses for larger fur babies – Read on to learn the controversy and solution.
This clinical trial used hemp derived Full Spectrum CBD Oil extracted from ethanol and steam – safe methods that allow more beneficial terpenes and cannabinoid strains to remain in the final product. CBN is the most significant anti-inflammatory cannabinoid strain and word is spreading.
“A recent survey reported that pet owners endorse hemp based treats and products because of perceived improvement in numerous ailments, as hemp products were moderately to very helpful medicinally. Some of the conditions thought to be relieved by hemp consumption were: pain, inflammation, anxiety and phobia, digestive system issue, and pruritus” Gamble, Lauri-Jo, et al. “Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.” Frontiers in Veterinary Science, vol. 5, 2018, pp. 165.
The thing is, consumers need to know what to look for when shopping for hemp products because there are no FDA regulations. Do not fear – CBD Girl is here and she’s the CBD watchdog. In a quick search, Roxy for Dogs from Hemplucid in Utah looked fine and it is full-spectrum. But their extraction method is CO2 which extracts beneficial terpenes. Recall that in the clinical trial, ethanol and steam extraction methods were preferred. Also, there was no COA, (certificate of analysis), for discerning pet owners to learn the cannaboids and their levels, the terpenes, or the levels of harmful substances such as pesticides, heavy metals, pathogens and mold. Consumers would need to request a copy of the COA that their product was derived from, which is a hassle.
That’s something else CBD Girl Next Door is good for in the hemp world. She’s a natural watchdog after all. As products are reviewed, they will be listed on this blog on the ‘Welcome List,’ should they qualify.
Pure Hemp Botanicals offers pet CBD, but I was confused when I read,
“Derive the many benefits of hemp in a 1 ml serving that offers the full array of naturally occurring cannabinoids and plant terpenes in a convenient 300mg or 750mg bottle.” First, the dosage is different than the clinical trial. Secondly…
The clinical trial used Full Spectrum CBD Oil, which the researchers called ‘CBD-rich.’ Their oil listed the CBD oil level at 10ml/mL, an equal mix of CBD & CBDA, .24mg/mL THC, .27mg/mL CBD, .11mg/mL CBG (the anti-inflammatory), and all others were less than .01mg/mL. Respectful to the variance of the new hemp industry, the trial compared 5 different batches and they showed less than 9% difference. Note that the trial’s CBD had a nice blend of cannabinoids from the ethanol and steam extraction.
Pure Hemp Botanicals’ shared a full profile COA that correlates to each batch of product on their website. That’s transparency and commitment. However, the Pet CBD Oil is an Isolate. It does not contain CBDA, or CBG or THC, so the relief does not last as long as full-spectrum and is not as effective.
Remember, all mammals have endocannabinoid receptors that respond to the natural cannabinoids found in hemp products like CBD. We do not take one part of our body and treat it without considering the rest of it and how it will respond. Now, let’s take a brief look at those cannabinoids, so you know why your fur baby needs a Full Spectrum CBD Oil backed by a full profile COA with excellent levels.
Full Spectrum CBD Oil’s entourage effect occurs as plant components work together to multiply, rather than add, to the potential benefits. This teamwork propels the ‘pain bell curve’ into a longer stretch so less medication needs to be administered. The most common listed on a COA are:
Cannabidiol acid (CBDA) is an anti-inflammatory inhibitor like aspirin, reduces nausea, and fights cancer.
Cannabidiol (CBD)’s antipsychotic properties are being studied as an alternative treatment for schizophrenia, psychosis, and anxiety.
Cannabidivarin (CBDV), is shown to be an effective anticonvulsant
Cannabichromene (CBC) is ten times more effective than CBD in treating anxiety and stress. Is analgesic, anti-inflammatory, anti-proliferative, antifungal, has antiviral properties, and promotes bone growth.
Cannabigerol (CBG) stimulates new brain cells (neurogenesis), including in the elderly. CBG continues to be heavily researched because it is rare and has so much potential. It is antibacterial, antifungal, and has anti-proliferative properties, and stimulates bone growth. CBG continues to be studied for Glaucoma, Inflammatory Bowel Disease (IBD), insomnia, depression, and epilepsy/MS/Dravet syndrome. CBG is derived from high-CBG strain whole plant extractions (not in isolates).
Cannabinol (CBN)’s anti-inflammatory action reduces the intraocular pressure associated with Glaucoma, used in dermal applications like patches for pain, in salves for pain.
Tetrahydrocannabinol (THC) THC is used to treat so many ailments, that I will cover that in a separate blog, including cancers, and diseases.
CBD Girl Next Door aims to have a ‘Welcome List’ of qualified Full Spectrum CBD Oil products in the very near future. Stay tuned and until then, give Fido a kiss from me, the cbd watchdog.
- Maccarrone, Mauro, et al. “Endocannabinoid Signaling at the Periphery: 50 Years After THC.”Trends in Pharmacological Sciences, vol. 36, no. 5, 2015, pp. 277-296.
- Marzo, Vincenzo D., Maurizio Bifulco, and Luciano D. Petrocellis. “The Endocannabinoid System and its Therapeutic Exploitation.” Nature Reviews Drug Discovery, vol. 3, no. 9, 2004, pp. 771-784.
- Abuhasira, Ran, et al. “Epidemiological Characteristics, Safety and Efficacy of Medical Cannabis in the Elderly.” European Journal of Internal Medicine, vol. 49, 2018, pp. 44-50.
- Di Marzo, Vincenzo, Nephi Stella, and Andreas Zimmer. “Endocannabinoid Signalling and the Deteriorating Brain.” Nature Reviews. Neuroscience, vol. 16, no. 1, 2015, pp. 30-42.